Nie Yusuke, Fujiyama Yoshiki, Shibaki Shumpei, Okamoto Riku, Okuno Kota, Oki Keiko, Watanabe Akiko, Kuroda Yu, Goto Takuya, Yokota Kazuko, Kojima Keita, Harada Hiroki, Kidachi Mikiko, Soeno Takafumi, Yokota Mitsuo, Kaida Takeshi, Nakamoto Shuji, Nishizawa Nobuyuki, Kubo Hidefumi, Tajima Hiroshi, Kaizu Takashi, Yamanashi Takahiro, Nakamura Masaki, Kitasato Hidero, Yoshida Tsutomu, Murakumo Yoshiki, Saegusa Makoto, Sangai Takafumi, Hiki Naoki, Naitoh Takeshi, Kumamoto Yusuke, Yamashita Keishi
Division of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Department of General-Pediatric-Hepatobiliary Pancreatic Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18039-5.
Secreted protein, acidic and rich in cysteine (SPARC) may play an important role in tumor microenvironment (TME) contribution to metastasis, however molecular mechanism of SPARC contribution to TME remains elusive.
In this study, SPARC molecular status was explored for its clinical and functional relevance to metastasis in the context of its stromal overexpression, which may represent colorectal cancer (CRC) progression.
SPARC expression was highly specific to cancer stroma of CRC tumors (GSE35608) and exhibited prognostic relevance. SPARC knockdown (KD) in cancer-associated fibroblasts (CAFs) resulted in diminished metastatic phenotypes, accompanied by robust suppression of COL1A1/COL3A1 expressions and multiple secretome genes. Among the secretome genes, CSF1 was closely associated with stromal SPARC expression, and it was demonstrated that the CSF1/CSF1R axis was required for SPARC-induced cancer invasion. Comprehensive selection by stromal specificity and its SPARC association identified CAF-associated genes (CAFGs), including classical CAFs markers and COL family genes, which were uniquely enriched as higher priority for prognosis. These findings suggest that SPARC-mediated induction of COL family genes and secretome in the TME may be primarily featured against the host rather than be protective.
Our present findings may aid in simplifying molecular understanding of aggressive TME and enrich bona-fide therapeutic targets for cancer metastasis.
分泌型酸性富含半胱氨酸蛋白(SPARC)可能在肿瘤微环境(TME)促进转移过程中发挥重要作用,然而SPARC对TME作用的分子机制仍不清楚。
在本研究中,探讨了SPARC分子状态与其在基质过表达背景下转移的临床和功能相关性,基质过表达可能代表结直肠癌(CRC)进展。
SPARC表达在CRC肿瘤(GSE35608)的癌基质中具有高度特异性,并显示出预后相关性。在癌相关成纤维细胞(CAF)中敲低(KD)SPARC导致转移表型减弱,同时COL1A1/COL3A1表达和多个分泌组基因受到强烈抑制。在分泌组基因中,CSF1与基质SPARC表达密切相关,并且证明CSF1/CSF1R轴是SPARC诱导的癌症侵袭所必需的。通过基质特异性及其与SPARC的关联进行综合筛选,确定了CAF相关基因(CAFG),包括经典的CAF标志物和COL家族基因,这些基因作为预后的更高优先级被独特富集。这些发现表明,SPARC介导的TME中COL家族基因和分泌组的诱导可能主要针对宿主而非起到保护作用。
我们目前的发现可能有助于简化对侵袭性TME的分子理解,并丰富癌症转移的真正治疗靶点。